Keersmaecker, B. de

t-cell response patient vaccine peptide study epitope antigen protein assay sequence vaccination control t-cell responses hla-b infection interruption value trial mutation virus cd 8+ t-cells el 9 epitope treatment interruption elispot treatment /s tissue antigens autologou count result immunol t-cell count study subject therapy figure nef-specific t-cell responses allard dendritic t-cell counts e 11d number subject recognition dendritic cells t cells dc-based analysis mutant point time points nol 6 peptide evolution plasma similarity electroporated phase clone proliferation replication molecule e 11d mutation ctl clone #59 universitair ziekenhuis brussel ifn -γ elisa hiv -1-infected patients antiretroviral therapy antiretroviral immunogenicity immunotherapy nef-specific brussel event eellktvrl hiv infection dc-based elispot tissue dc-based elispot assay regression mimicry vaccine-specific t-cell responses